Endogenous agmatine inhibits cerebral vascular matrix metalloproteinases expression by regulating activating transcription factor 3 and endothelial nitric oxide synthesis.

Source:http://linkedlifedata.com/resource/pubmed/id/20560878

Download in:

View as

General Info

PMID
20560878